Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invictus MD Strategies Corp (IVITF)

Invictus MD Strategies Corp (IVITF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0100 +38.00%
on 08/03/20
0.0280 -50.71%
on 07/14/20
-0.0092 (-40.00%)
since 07/13/20
3-Month
0.0100 +38.00%
on 08/03/20
0.0500 -72.40%
on 06/15/20
-0.0247 (-64.16%)
since 05/13/20
52-Week
0.0001 +13,700.00%
on 05/11/20
0.2861 -95.18%
on 08/15/19
-0.2563 (-94.89%)
since 08/13/19

Most Recent Stories

More News
Invictus Announces Signing of a Purchase Agreement

Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today that it has entered into an investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage")....

IVITF : 0.0125 (-16.67%)
Invictus MD Strategies Corp. - Change of Management

Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced that Ms. Harbir Toor has ceased to be the Company's Chief Financial Officer, effective immediately. The Company wishes to thank Ms....

IVITF : 0.0125 (-16.67%)
Invictus Announces Director Resignation

Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today the resignation of Mr. Marc Ripa from, and appointment of Ms. Brenda Dixon to, the Board of Directors of the Company. Ms. Dixon...

IVITF : 0.0125 (-16.67%)
Invictus MD Strategies Corp. - Notice of Sale and Investment Solicitation Process

INVICTUS MD STRATEGIES CORP. (NEX: GENE.H;) (the "Company") announced that the Company, Greener Pastures MD Ltd., Acreage Pharms Ltd. ("Acreage") and 2015059 Alberta Ltd. (collectively, the "Invictus Group")...

IVITF : 0.0125 (-16.67%)
Invictus Announces Resignations

INVICTUS MD STRATEGIES CORP. (NEX: GENE.H) (the "Company") announced today the resignations of Mr. Richard Lee from the Board of Directors of the Company and Ms. Kathy Love, Corporate Secretary of the...

IVITF : 0.0125 (-16.67%)
IIROC Trading Halt - GENE.H

The following issues have been halted by IIROC:

IVITF : 0.0125 (-16.67%)
Invictus Obtains Further Court Approvals in Connection with CCAA Proceedings

(the "") announces that on Monday, February 24, 2020, the Supreme Court of British Columbia (the "") granted an amended and restated initial order (the "") under the (Canada) (""). The Amended and Restated...

GENE.VN : 0.050 (unch)
IVITF : 0.0125 (-16.67%)
IIROC Trading Resumption - GENE

Trading resumes in:

IVITF : 0.0125 (-16.67%)
INVICTUS GRANTED CREDITOR PROTECTION AND WILL COMMENCE A STRATEGIC REVIEW

Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the "Company") announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the "Court") issued an order granting...

IVITF : 0.0125 (-16.67%)
IIROC Trading Halt - GENE

The following issues have been halted by IIROC:

IVITF : 0.0125 (-16.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IVITF with:

Key Turning Points

2nd Resistance Point 0.0183
1st Resistance Point 0.0166
Last Price 0.0125
1st Support Level 0.0117
2nd Support Level 0.0085

See More

52-Week High 0.2861
Fibonacci 61.8% 0.1768
Fibonacci 50% 0.1431
Fibonacci 38.2% 0.1094
Last Price 0.0125
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar